Articles tagged with Antibiotics
Researchers developed a new method to measure how effectively antibiotics kill bacteria, crucial for treating complex infections. The 'antimicrobial single-cell testing' method predicts treatment success by observing individual bacteria under different conditions.
The study highlights the multifunctional natural substitute for antibiotics in swine production, demonstrating broad antimicrobial, antioxidant, anti-inflammatory, and immune-regulating effects. Dietary supplementation improves intestinal barrier integrity, increases growth metrics, and reduces fecal E. coli.
Certain microbes can act as community protectors by breaking down antibiotics and stabilizing entire microbial ecosystems. Antibiotic degraders create safer microenvironments, allowing sensitive microbes to survive.
The new clinical standards for antimicrobial stewardship in tuberculosis care aim to integrate TB into existing AMS frameworks, strengthening surveillance and resistance monitoring. The standards prioritize effectiveness, safety, and resistance prevention, promoting structured expert consultation services and targeted testing.
The study will select the exact phage that is appropriate for each patient's bacteria, and aims to reduce antibiotic use and healthcare costs. Bacteriophages have been shown to be effective against resistant bacteria causing urinary tract infections.
A study published in the International Journal of Infectious Diseases found that delafloxacin inhibits Legionella replication more effectively than levofloxacin. The antibiotic demonstrates promising intracellular activity, which could support further clinical investigation as a potential treatment for Legionnaires' disease.
A team of researchers has identified two proteins critical to the destruction of red blood cells by the Oroya fever pathogen. This discovery paves the way for a potential novel therapy against this deadly neglected tropical disease.
A new single-dose oral medication called zoliflodacin shows promise as a treatment for antibiotic-resistant gonorrhoea, with over 90% of infections cured at genital sites. The medication is well-tolerated and has the potential to improve global efforts to control drug-resistant gonorrhea infections.
Researchers at HIPS have fully elucidated the biosynthetic pathway of biphenomycins, a potent antibiotic family against Gram-positive pathogens. They can now produce sufficient quantities and create new variants with improved pharmaceutical properties to combat drug-resistant S. aureus infections.
A study found that lung microbiomes play a significant role in pneumonia, with patients having oral-like pneumotypes more likely to recover. The researchers identified four distinct microbial patterns, or 'pneumotypes,' associated with different types of pneumonia.
A new seaweed-based carbon catalyst has been developed that can rapidly break down antibiotic norfloxacin in water without using toxic metals or sulfur chemicals. The catalyst, made from kappa carrageenan and doped with nitrogen and sulfur, shows high specific surface area and degrades antibiotics through non-radical pathways.
Researchers at Martin Luther University Halle-Wittenberg have developed a promising new substance that inhibits the ability of tuberculosis bacteria to produce energy and causes them to die. The compound, PRP020, targets the pathogen's ATP synthase but attacks a different site than existing drugs like bedaquiline.
Researchers found that plant phenolic acids can dramatically boost the activity of existing antibiotics against multidrug resistant E. coli, reducing the chance of new resistance emerging. The compounds also make it easier for antibiotics to enter and stay inside bacterial cells.
Researchers discovered that antibiotics can induce the production of pro-inflammatory compounds in the gut microbiome, which stimulates the immune system and induces antimicrobial peptides. This finding could lead to new therapeutic properties for these compounds in restructing the gut microbiome.
Researchers at HIPS and Helmholtz Centre for Infection Research discovered that tolcapone interacts with LecA protein, a key component of Pseudomonas aeruginosa. The study identified several derivatives that inhibit LecA significantly more strongly than tolcapone.
A study reveals that competition for biotin, a vital vitamin, drives interactions between harmful Staphylococcus aureus and harmless commensal bacteria. This resource scarcity could lead to new strategies for fighting multi-resistant germs.
A new study identifies how sulfamethoxazole, a common antibiotic, affects denitrification in estuarine sediments. The results show that the antibiotic disrupts the balance of nitrogen cycling processes, leading to increased nitrous oxide emissions and greenhouse gas warming.
A novel nanogel technology has been developed to kill drug-resistant bacteria, including Pseudomonas aeruginosa and Escherichia coli, with high selectivity and efficiency. The technology uses a heteromultivalent nanogel that binds to specific proteins on the bacterial surface, disrupting the membrane and leading to rapid bacterial death.
Researchers at Institut Pasteur found that aminoglycosides use sugar transporters to enter bacteria, increasing their effectiveness and potentially reducing the need for high doses. By doubling the number of transporters, they improved antibiotics' penetration rate and efficacy in even the most resistant E. coli strains.
A new study shows that even small amounts of antibiotics in the environment can significantly accelerate the spread of antibiotic resistance genes among bacteria. The research found that low concentrations of antibiotics can stabilize existing resistance and promote the development of new resistance traits.
Researchers have demonstrated that doxycycline can improve survival rates and neurological outcomes in children with Central Nervous System Tuberculosis. The study found that treating CNS-TB laboratory models with doxycycline alongside standard TB drugs suppressed inflammation, preserved brain tissue, and improved vascular integrity.
Researchers used an experimental evolution approach to map genetic mutations in A. baumannii treated with tigecycline and colistin, confirming and extending existing knowledge on major mechanisms of resistance. The study's findings aim to develop genomics-based predictions of drug resistance and susceptibility.
A clinical trial found that antibiotics within 24 hours of an obstetric tear can significantly reduce the risk of clinically relevant wound complications. The treatment group experienced fewer complications and reported better wellbeing compared to the placebo group. This finding supports the use of prophylactic antibiotics in routine ...
A University of East Anglia study found that treating patients at home with IV antibiotics can save the NHS over £3,500 per patient and potentially free-up vital hospital beds. The treatment involves having antibiotics prepared at home and continuously delivered into the bloodstream by an elastomeric pump.
Researchers have discovered a promising new antibiotic, pre-methylenomycin C lactone, which is over 100 times more active than the current antibiotic methylenomycin A. This finding provides hope in the fight against antimicrobial resistance (AMR), which affects millions of people worldwide.
Researchers optimized lab culture conditions to boost levels of low-abundance chlorinated compounds in slime mold cells, identifying CDF-2 and CDF-3 as potent antibiotics against Gram-positive bacteria. The compounds' similar molecular structure suggests a critical role in protecting against harmful bacteria.
A team of researchers has developed a 'bio-photovoltage soil-microbe battery' that uses sunlight energy to power the breakdown of antibiotic pollutants in the dark. The system, formed by common soil bacteria and iron minerals, captures and releases solar energy to trigger chemical reactions degrading antibiotics.
A study published in The Lancet Regional Health – Western Pacific found that most newborn infections in Southeast Asia are caused by bacteria unlikely to respond to current treatments, highlighting the need for updated diagnostic and treatment guidelines. Locally relevant data is crucial for guiding routine medical decisions, and new a...
Researchers from UCL and Imperial College London have discovered how life-saving antibiotics called polymyxins target the outer layer of Gram-negative bacteria. By triggering the production and shedding of this armor, polymyxins create gaps in the cell's defenses, allowing the antibiotic to enter and kill the bacteria.
This comprehensive metagenomic survey reveals vast gut microbiome diversity, with 21,902 species-level genome bins identified. The study also uncovers a significant reservoir of previously uncharacterized microbes and identifies high-risk antibiotic resistance genes across 14 mammal species.
Researchers found that providers know antibiotics are wrong for most diarrhea cases but prescribe them anyway due to patient expectations. Targeted interventions empowering caregivers and public campaigns can slash misuse of antibiotics in India's private sector.
Researchers found that combining biochar with starch accelerates oxytetracycline degradation and reduces its transfer into lettuce, a widely consumed leafy vegetable. The study's results suggest a cost-effective and sustainable solution for reducing antibiotic residues in farmland.
A novel, low-cost catalyst made from peanut shell-derived biochar and BiFeO₃ achieves rapid inactivation of antibiotic-resistant bacteria (ARB) within minutes. The system demonstrates high efficiency and durability, offering a potential solution to tackle antibiotic resistance pollution in aquaculture wastewater.
Researchers discover how heme bound proteins catalyze hydrogen sulfide signaling in bacteria, leading to stress tolerance and antibiotic resistance. Disrupting this mechanism could inspire new antibiotic strategies against drug-resistant infections.
Researchers funded by the National Institutes of Health found that a single injection of benzathine penicillin G successfully treated early syphilis just as well as the three-injection regimen used by many clinicians. Biological markers showed that 76% of participants in the single-dose group had a serologic response to treatment, comp...
Researchers at Penn Engineering introduced AMP-Diffusion, a generative AI tool that designed tens of thousands of new antimicrobial peptides with bacteria-killing potential. The most potent AMPs performed as well as FDA-approved drugs without detectable adverse effects.
Researchers developed a binder-free 'surface self-bounded photocatalytic membrane' that efficiently produces green H₂O₂ while annihilating antibiotics in water. The membrane achieved high activity, rapid pollutant removal, and low maintenance costs.
Research from the University of South Australia finds that ibuprofen and paracetamol drive antibiotic resistance when used individually, but amplifying it when combined. The study also reveals that common bacteria like E. coli become highly resistant to antibiotics and multiple other medications.
A large-scale study published in PLOS Medicine found no association between early life antibiotic exposure and the development of autoimmune diseases in children. Researchers analyzed data from over 4 million Korean children and discovered no increased risk of Type 1 diabetes, Juvenile idiopathic arthritis, or other autoimmune conditions.
Researchers designed over 36 million compounds using generative AI algorithms and computationally screened them for antimicrobial properties. The top candidates show promise against Neisseria gonorrhoeae and Staphylococcus aureus (MRSA) by novel mechanisms that disrupt bacterial cell membranes.
A National Institutes of Health (NIH)-supported clinical trial found that two intravenous doses of the antibiotic dalbavancin seven days apart are as good as daily IV doses of conventional antibiotics over four to six weeks for treating complicated Staphylococcus aureus bloodstream infections. The study results provide clear evidence f...
A team of researchers developed an AI tool called PepMLM that can design small molecules to stick to and break down harmful proteins in the body. This breakthrough could lead to new treatments for diseases that have resisted traditional drug development, including certain cancers, brain disorders, and viral infections.
Researchers have successfully increased the susceptibility of Candida albicans to drug treatment through light-activated therapy. Combining photodynamic inactivation with antifungal amphotericin B reduced fungal growth by up to 87.5% and demonstrated potential as an alternative to combat antimicrobial resistance.
Researchers at the University of Pennsylvania used AI to identify previously unknown compounds in Archaea that could fuel the development of next-generation antibiotics. The study, published in Nature Microbiology, found that 93% of the identified archaeasins demonstrated antimicrobial activity against drug-resistant bacteria.
A nationwide observational study found significant regional differences in antibiotic use among newborns in Sweden, with the goal of treating no more than one percent of infants while maintaining low sepsis prevalence. The study highlights the need for increased awareness and improved practices to reduce overuse of antibiotics.
The book examines antibiotic-induced reproductive toxicity, microbiome alterations, and emerging concerns around antibiotic resistance. It provides critical insights for clinicians, pharmacists, researchers, and students in reproductive medicine and pharmacology.
A new platform identifies drug resistance genes in the environment, allowing for proactive optimization of antibiotics. By analyzing natural structural variants and resistance mechanisms, researchers can predict future threats and develop more resilient treatments.
A study of 22 million urgent care visits found 12.4% of patients received antibiotics, 9.1% glucocorticoids, and 1.3% opioids for generally inappropriate diagnoses. The trends highlight the need for improved clinician knowledge, patient demand, and decision support.
A study found that antibiotic resistance genes in gut bacteria predicted the risk of sepsis and death over 17 years. A high resistance burden was associated with a 40% higher risk of all-cause mortality, particularly for deaths related to respiratory infections.
Cyanobacteria's microalgae-based technologies effectively remove antibiotics from wastewater through mechanisms attributed to the identified nitroreductase enzyme. Engineered bacteria expressing this enzyme degrade chloramphenicol with high efficiency, offering a sustainable biocatalyst for antibiotic pollution control.
A recent study in the Netherlands found 15% of men who have sex with men and transgender individuals recently used doxycycline as post- or pre-exposure prophylaxis (PrEP), highlighting an increase in informal use. The high intention to use PrEP among the population raises concerns about potential antimicrobial resistance (AMR) and chan...
Researchers at Lund University have identified a potential therapeutic breakthrough for melanoma, a deadly form of skin cancer. By targeting mitochondrial energy production and protein synthesis, existing antibiotics and inhibitors can effectively eliminate cancer cells while sparing healthy skin cells.
Researchers from Pusan National University have developed engineered bacterial vesicles that use a novel surface-displaying protein to selectively target and eliminate E. coli and S. aureus bacteria. These vesicles, derived from lactic acid bacteria, offer a promising alternative to conventional antibiotics.
A new study has identified specific proteins in umbilical cord blood that signal acute systemic inflammation, providing a non-invasive means to diagnose early onset sepsis in preterm newborns. This discovery could lead to the development of a diagnostic test to avoid prolonged antibiotic exposure for infants at risk.
The article discusses how emerging contaminants like agricultural pesticides and medicines are impacting water quality in developing countries. The presence of these pollutants is linked to toxic effects on humans and ecosystems, with many being undetected or under-regulated.
A daily dose of trimethoprim-sulfamethoxazole reduced the proportion of preterm births by 40% in pregnant women with HIV. The antibiotic also increased birth weight by 177 grams, improving health outcomes for babies. Researchers hope to confirm these findings in future trials.
A recent study found that Metagenomic next-generation sequencing (mNGS) can detect pathogens in 86% of cases, outperforming conventional microbiological tests which identified pathogens in only 67% of cases. mNGS guides treatment decisions and improves patient outcomes by detecting rare/atypical pathogens.
A large cohort study found that early antibiotic treatment did not significantly improve outcomes for patients with nonsevere COVID-19. The results argue against routine antibiotic use in this population due to associated risks.
Researchers have discovered that microalgae species can remove antibiotic residues from water, including sulfamethoxazole and trimethoprim. This process also produces biomass with potential commercial value, including biodiesel production.
Research suggests that antibiotics taken during infancy, especially in the first three months, may lead to earlier onset of puberty in girls. The study, which analyzed data on over 322,000 children in South Korea, found a significant association between early antibiotic exposure and increased risk of central precocious puberty.